When treating AML cell lines in combination with PRI-724, and chemotherapy sorafenib, the combination synergistically induced apoptosis AML cell lines, AML blasts, and FLT3-mutated CD34+CD38− AML stem/progenitor cells. The gene discussed is CD38; the disease is acute myeloid leukemia.